A phase 1B/2 trial of avelumab and pepinemab as second line for metastatic pancreatic adenocarcinoma
| Autor: | Ruffolo, L.I., Jackson, K.M., Ullman, N.A., Burchard, P.R., Georger, M., Jewell, R., Belt, B.A., Fields, R.C., Mulkerin, D., Evans, E.E., Fisher, T.L., Zauderer, M., Yeh, J., Linehan, D.C. |
|---|---|
| Zdroj: | In HPB 2023 25 Supplement 1:S159-S159 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|